Daunorubicin Hydrochloride Injection

Daunorubicin Hydrochloride Injection USP 20 mg

Indications:    

• Acute myeloblastic Leukemia
• Neuroblastoma
• Acute Lymphoblastic Leukemia
• Rhabdomyosarcoma
• Acute Non-Lymphatic Leukemia of adults
• Remission induction in acute Lymphatic Leukemia of children and adults

Dosage :

Starting Doses :
The recommended dosage in each individual may vary from 0.5 to 3 mg/ kg.

Acute non-lymphoytic leukemia
Patients <60 yrs. of age : 45mg/m²/day.

Patients >60 yrs. of age : 30mg/m²/day.

Acute Lymphocytic Leukemia (ALL)
Paediatric : 25mg/m2

Adult : 45mg/m2

Dosage Adjustment :

Renal Impairment : Not Required.

Hepatic Impairment : Required.
       
Packing: 5 Vials of 20 mg

We also deals in: